Handbook_Volume III

52 Ringraziamenti Si ringrazia la Sezione AIL Ravenna per il supporto alle nostre attività cliniche e di ricerca. [21] Lee SJ, High-Resolution donor-recipient HLA matching contributes to success of unrelated donor marrow transplantation. Blood. 2007;110(13):4576-4583 [22] Pidala J, Non-permissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood. 2014;124(16):2596-2606 [23] Ayuk F, Relative impact of HLA matching and non-HLA donor characteristics on outcomes of allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant. 2018;24(12):2558-2567 [24] Robinson TM, Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide. Semin Hematol. 2016;53(2):90-97 [25] El Fakih R, Post-transplant cyclophosphamide use in matched HLA donors: a review of literature and further application. Bone Marrow Transplant. 2020;55(1)1 DOI:10.1038/s4140559-0190547-8 [26] Pidala J, Aminoacid substitution at peptide-binding pockets of HLA class I molecules increases the risk of severe acute GvHD and mortality. Blood. 2013;122(22):3651-3658 [27] Petersdorf EW, High HLA-DP expression and graft-versushost disease. N Engl J Med. 2015;373(7):599-609 [28] Hurley CK, The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors. Blood. 2013;121(23):48004806 [29] Fernandez-Vina MA, Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood. 2014;123(8):1270-1278 [30] Cullen M, Characterization of recombination in the HLA class II region. Am J Hum Genet. 1997;60(2):397-407 [31] Petersdorf EW, The biological significance of HLA-DP gene variation in hematopoietic cell transplantation. Br J Hematol. 2001;112(4):988-994 [32] Fleischhauer K, Effect of T-cell epitope matching at HLADPB1 in recipients of unrelated donor hematopoietic cell transplantation: a retrospective study. Lancet Oncol. 2012;13(4):366374 [33] Moyer AM, Clinical outcome of HLA-DP1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogenic stem cell transplant. Eur J Haematol. 2017;Sep;99(3):275282 [34] Meurer T, Dissecting genetic control of HLA-DPB1 expression and its relation to structural mismatch models in hematopoietic tem cell transplantation. Front Immunol. 2018;9:2236 [35] Morishima S, Evolutionary basis of HLA-DPB1 alleles affects acute GvHD in unrelated donor stem cell transplantation. Blood. 2018;131(7):808-817 [36] Geneugelijk K. Exploratory study of predicted indirectly recognizable HLA epitopes in mismatched hematopoietic cell transplantation. Front. Immunol, 24 April 2019 | https://doi. org/10.3389/fimmu.2019.00880 [37] Wroblewski EE, Two to tango: co-evolution of hominid natural killer cell receptors and MHC. Front. Immunol 2019;10:177. [38] Steinle A, Interactions of Human NKG2D with its ligands MICA, MICB and homologs of the mouse RAE-1 protein family. Immunogenetics. 2001;53(4), 279-287. [39] Martin PJ, Recipient and donor genetics variants associated with mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2020;4(14),3224-3223. [40] Maskalan M, The MHC gamma block matching: impact on unrelated hematopoietic stem cell transplantation outcome. Hum Immunol. 2020;Jan;81(1):12-17 Bibliografia [1] Fleischhauer K, Selection of matched unrelated donors moving forward: from HLA allele counting to functional mathing. Hematology Am Soc Hematol Educ Program 2019 Dec 6;2019(1):532538 [2] Spierings E, Minor histocompatibility antigens: past, present and future. Tissue Antigens. 2014;84:374-60 [3] Heidenrreich S, Reduction in relapse after unrelated donor stem cell transplantation by KIR-based graft selection. Front Immunol. 2017;8:41 [4] Trowsdale J, Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet. 2013;14:301-23 [5] Spierings E, Histocompatibility. The EBMT Handbook, 2019; https://doi.org/10.1007/978-3-030-02278-5_9 [6] Martin M, Recombination rates across the HLA complex: use of microsatellites as a rapid screen for recombinant chromosomes. Hum Mol Genet. 1995;4:423-8 [7] Tiercy JM, How to select the best available related or unrelated donor of hematopoietic stem cells? Haematologica. 2016;101(6): 680-87 [8] Fleischhauer K, Immunogenetics laboratory. In Gluckman E. Establishing a Hematopoietic Stem Cell Transplantation Unit: a practical guide. Cham, Switzerland: Springer; 2018 [9] Archbold JK, T cell allorecognition and MHC restriction-a case of Jekyll and Hyde? Mol Immunol. 2008;45:583-98 [10] Gokmen MR, The importance of the indirect pathway of allorecognition in clinical transplantation. Curr Opin Immunol. 2008;20:560-74 [11] Erlich H, HLA DNA typing: past, present and future. Tissue antigens. 2012;80:1-11. [12] Nunes E, Definition of histocompatibility typing terms. Blood. 2011;118(23):e180-e183 [13] Nielsen R, Genotype and SNP calling from next-generation sequencing data. Nat Rev Genet. 2011;Jun;12(6):443-51 [14] Mayor N, Recipients receiving better HLA-matched hetamopoietic cell transplantation grafts, unocvered by a novel HLA typing method, have a superior survival: a retrospective study. Biol Blood Marrow Transplant. 2019;25:443-450 [15] Hurley CK, Regarding “Recipients receiving better HLA-matched Hematopoietic cell transplantation grafts, Uncovered by a novel HLA typing method, have a superior Survival: a retrospective study”. Biol Blood Marrow Transplant. 2019;25;e268269 [16] Dehn J, Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. Blood. 2019;134(12):924-934 [17] Ciurea SO, Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hemapoietic stem cell transplantation. Blood 2011;118(22):5957-5964 [18] Little AM, BSHI guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation. Int J Immunogenet. 2021;48:75-109 [19] Valcarcel D, One-antigenmismatched related versus HLA-matched unrelated donor hematopoietic stem cell trasplantation in adult with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing. Biol Blood Marrow Transplat. 2011;17(5) 640-648 [20] Eapen M, Center for International Blood and Marrow Transplant Research, Eurocord, and the European Group for Blood and Marrow Transplantation. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbelical cord blood transplantation for hematologic malignancy. Blood. 2014;123(1):133-140